Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Immunotargets and Therapy|July 22, 2025
Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective StudyJiangtao Liu, Yan Wang, Li Cui, et al.
High Altitude Medicine & Biology|October 20, 2025
Using Mendelian Randomization to Dissect the Relationship Between High-Altitude Adaptation and Liver Diseases/TraitsTianzhun Wu, Ruofan Li, Qingfeng Song, et al.
International Immunopharmacology|February 6, 2024
Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinomaYan Xu, Fang Sun, Yuying Tian, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 27, 2023
Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysisYinbiao Cao, Haowen Tang, Bingyang Hu, et al.
European Urology|December 11, 2017
Robot-assisted Retrohepatic Inferior Vena Cava Thrombectomy: First or Second Porta Hepatis as an Important Boundary LandmarkBaojun Wang, Hongzhao Li, Qingbo Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 7, 2022
Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted NanodrugBozhao Li, Xiuping Zhang, Zhouliang Wu, et al.
Journal for Immunotherapy of Cancer|September 20, 2023
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trialWenwen Zhang, Shuang Tong, Bingyang Hu, et al.
Bioscience Trends|December 25, 2024
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Wenwen Zhang, Junning Cao, et al.
Pageof 5